TY - JOUR
T1 - Chemical modification of the carboxyl terminal of nisin a with biotin does not abolish antimicrobial activity against the indicator organism, kocuria rhizophila
AU - Maher, Sam
AU - Vilk, Greg
AU - Kelleher, Fintan
AU - Lajoie, Gilles
AU - McClean, Siobhán
N1 - Funding Information:
Acknowledgments This study was supported by the Programme for Research in Third Level Institutions (PRTLI) Cycle 3 as administered by HEA, Ireland. The authors would like to thank Dr. Venkat Reddy Thangella for his assistance in the preparation of this manuscript.
PY - 2009/9
Y1 - 2009/9
N2 - Nisin is an antimicrobial peptide that is widely used for food preservation. Although it has potent activity against a number of food pathogens, suggesting potential therapeutic applications, its potential for clinical use is limited by proteolytic susceptibility and poor oral bioavailability. Derivatization of nisin could overcome these issues; however, many nisin analogues, prepared by modification at the N-terminal and C-terminal have previously been shown to be inactive. A method for the C-terminal modification was developed using biotinylation as a model derivative. Purification of the modified nisin was carried out using reverse phase chromatography. Confirmation of nisin modification was confirmed by Mass Spectroscopy. The C-terminal modification of nisin resulted in only a twofold reduction in antimicrobial activity of the conjugate against the indicator organism, Kocuria rhizophila. The C-terminal modification could be used to increase the therapeutic potential of nisin by creating more favourable physicochemical characteristics. This is the first study that showed that nisin modification can be carried out successfully without destroying its antimicrobial activity.
AB - Nisin is an antimicrobial peptide that is widely used for food preservation. Although it has potent activity against a number of food pathogens, suggesting potential therapeutic applications, its potential for clinical use is limited by proteolytic susceptibility and poor oral bioavailability. Derivatization of nisin could overcome these issues; however, many nisin analogues, prepared by modification at the N-terminal and C-terminal have previously been shown to be inactive. A method for the C-terminal modification was developed using biotinylation as a model derivative. Purification of the modified nisin was carried out using reverse phase chromatography. Confirmation of nisin modification was confirmed by Mass Spectroscopy. The C-terminal modification of nisin resulted in only a twofold reduction in antimicrobial activity of the conjugate against the indicator organism, Kocuria rhizophila. The C-terminal modification could be used to increase the therapeutic potential of nisin by creating more favourable physicochemical characteristics. This is the first study that showed that nisin modification can be carried out successfully without destroying its antimicrobial activity.
KW - Antimicrobial peptide
KW - Biotinylation
KW - C-terminal modification
KW - Nisin
KW - Therapeutic application
UR - http://www.scopus.com/inward/record.url?scp=67651147994&partnerID=8YFLogxK
U2 - 10.1007/s10989-009-9179-y
DO - 10.1007/s10989-009-9179-y
M3 - Article
AN - SCOPUS:67651147994
SN - 1573-3149
VL - 15
SP - 219
EP - 226
JO - International Journal of Peptide Research and Therapeutics
JF - International Journal of Peptide Research and Therapeutics
IS - 3
ER -